Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus.

Proceedings of the National Academy of Sciences of the United States of America
Aleksandar K StanicA S Major

Abstract

Patients with systemic lupus erythematosus (SLE) have accelerated atherosclerosis. The underlying mechanisms are poorly understood, and investigations have been hampered by the absence of animal models that reflect the human condition of generalized atherosclerosis and lupus. We addressed this problem by transferring lupus susceptibility to low-density lipoprotein (LDL) receptor-deficient (LDLr-/-) mice, an established model of atherosclerosis, creating radiation chimeras with NZM2410-derived, lupus-susceptible, B6.Sle1.2.3 congenic or C57BL/6 control donors (LDLr.Sle and LDLr.B6, respectively). LDLr.Sle mice developed a lupus-like disease characterized by production of double-stranded DNA autoantibodies and renal disease. When fed a Western-type diet, LDLr.Sle chimeras had increased mortality and atherosclerotic lesions. The plaques of LDLr.Sle mice were highly inflammatory and contained more CD3+ T cells than controls. LDLr.Sle mice also had increased activation of CD4+ T and B cells and significantly higher antibody to oxidized LDL and cardiolipin. Collectively, these studies demonstrate that the lupus-susceptible immune system enhances atherogenesis and modulates plaque composition.

References

Feb 1, 1976·The American Journal of Medicine·M B UrowitzM A Ogryzlo
Jun 1, 1985·The Journal of Experimental Medicine·K HayakawaL A Herzenberg
Feb 1, 1993·Metabolism: Clinical and Experimental·R J Shapiro
May 1, 1996·Mammalian Genome : Official Journal of the International Mammalian Genome Society·L MorelE K Wakeland
Jul 1, 1997·Journal of Clinical Immunology·E K WakelandM Yui
May 26, 1999·Cardiovascular Research·A C van der Wal, A E Becker
Jun 26, 1999·The Journal of Biological Chemistry·M F LintonS Fazio
Jan 13, 2000·Current Opinion in Immunology·E K WakelandL Morel
Jun 7, 2000·Proceedings of the National Academy of Sciences of the United States of America·L MorelE K Wakeland
Jul 25, 2000·Clinical Reviews in Allergy & Immunology·J GeorgeY Shoenfeld
Nov 4, 2000·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·R P KirznerR A Good
Nov 12, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Amy S MajorMacRae F Linton
Jul 10, 2003·Autoimmunity Reviews·P A BaconG D Kitas
Sep 30, 2003·Journal of the American Society of Nephrology : JASN·Susanne BroLars B Nielsen
Dec 19, 2003·The New England Journal of Medicine·Mary J RomanJane E Salmon
Dec 19, 2003·The New England Journal of Medicine·Yu AsanumaC Michael Stein
Mar 23, 2004·Annual Review of Immunology·Georg WickQingbo Xu
Oct 9, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Amy S MajorMacrae F Linton
May 25, 2005·Journal of Internal Medicine·J Frostegård
Jun 14, 2005·The Journal of Clinical Investigation·Jiankun ZhuChandra Mohan

❮ Previous
Next ❯

Citations

Nov 9, 2012·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Betul SozeriSevgi Mir
Feb 1, 2008·Nature Clinical Practice. Rheumatology·Sally AyoubEric F Morand
Sep 14, 2010·The Journal of Biological Chemistry·Ashley J WilhelmMary G Sorci-Thomas
Jul 13, 2013·Current Opinion in Rheumatology·Jason S Knight, Mariana J Kaplan
Nov 11, 2006·Current Opinion in Lipidology·Alan Daugherty, Debra L Rateri
Sep 29, 2011·Annals of the Rheumatic Diseases·Sander I van LeuvenAmy S Major
Oct 4, 2012·American Journal of Physiology. Endocrinology and Metabolism·Curtis L GabrielAmy S Major
Nov 26, 2011·Journal of Innate Immunity·Lorenza FrancescutCordula Stover
Mar 17, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Ashley J WilhelmMary G Sorci-Thomas
Jul 16, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Macrae F Linton, Sergio Fazio
Nov 18, 2009·Circulation·Tanya N MayadasNaotake Tsuboi
Sep 15, 2010·Journal of Clinical Biochemistry and Nutrition·Masahide HamaguchiYutaka Kawahito
Sep 24, 2011·International Journal of Inflammation·Tamar R Aprahamian, Flora Sam
Apr 23, 2009·Prostaglandins & Other Lipid Mediators·Janusz H Kabarowski
Apr 28, 2009·Biochemical and Biophysical Research Communications·Kerry W S KoLawrence Chan
Mar 8, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Zhongjie MaRobert A Eisenberg
Nov 6, 2007·Seminars in Arthritis and Rheumatism·Cristina C BeliznaHervé Lévesque
Dec 8, 2011·Journal of the American Academy of Nurse Practitioners·Marcia RobinsonLeanne M Currie
Oct 23, 2012·Atherosclerosis·Chiara Bolego
Jan 29, 2016·Arteriosclerosis, Thrombosis, and Vascular Biology·Menno P J de Winther
Apr 9, 2013·Journal of the American Heart Association·Yan LiuJacek Hawiger
Apr 21, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Emmanuel L GautierPhilippe Lesnik
Jan 18, 2019·Expert Review of Clinical Immunology·Vasiliki KoulouriClio P Mavragani
Oct 1, 2012·International Journal of Clinical Rheumatology·Ashley J Wilhelm, Amy S Major
Aug 1, 2013·Physiological Reviews·Paul N Hopkins
Jan 18, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Amanda A WatkinsIan R Rifkin
Nov 10, 2018·Nature Reviews. Cardiology·Andrew P SageZiad Mallat

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.